Published on 30 May 2016
Thank you to reviewers 2015
2.422 views
Published on 30 May 2016
2.422 views
Published on 30 May 2016
2.482 views
Published on 30 May 2016
2.534 views
Published on 30 May 2016
2.566 views
Published on 04 May 2016
Author(s): Alfredo García Arieta, PhD, Henrike Potthast, PhD, Hubert Leufkens, PhD, Jan Welink, John Gordon, PhD, Luther Gwaza, BPharm, MPhil, Marc Maliepaard, PhD, Matthias Stahl, MD
adjusted indirect comparisons, bioequivalence, drug switching, generic medicines, interchangeability, prequalification
DOI: 10.5639/gabij.2016.0502.015
12.493 views
Published on 04 May 2016
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2016.0501.001
3.170 views
Published on 27 April 2016
Author(s): Alejandra Babini, Associate Professor Valderilio Feijó Azevedo, MD, PhD, MSc, Igor Age Kos, Pablo Matar, PhD, Professor Fabio V Teixeira, MSc, MD, PhD
biosimilarity, extrapolation, infliximab, interchangeability, monoclonal antibodies, rituximab
DOI: 10.5639/gabij.2016.0502.017
12.331 views
Published on 18 April 2016
Author(s): Professor Philip D Walson, MD
chart review, consent, retrospective, waiver
DOI: 10.5639/gabij.2016.0501.004
16.122 views
Published on 18 April 2016
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2016.0501.012
4.966 views
Published on 07 April 2016
Author(s): Falk Ehmann, MD, PhD, MSc, Ruben Pita, PharmD, LLM
complex pharmaceutical forms, EMA, nanomedicines, regulatory science
DOI: 10.5639/gabij.2016.0501.008
14.875 views
Published on 07 April 2016
Author(s): Professor Gerrit Borchard, PharmD, PhD
drug quality, ICH, non-biological complex drug (NBCD), Ph. Eur., pharmacopoeia, USP
DOI: 10.5639/gabij.2016.0501.009
18.103 views
Published on 07 April 2016
Author(s): Joshua D Brown, PharmD, MS
generic medicines, low-cost generic drug programs, quality assessment, United States healthcare system
DOI: 10.5639/gabij.2016.0501.003
4.757 views